More than three quarters of 200 hospitals surveyed from across the globe report that their paediatric cancer care services had been impacted by the COVID-19 pandemic, according to a study published in the Lancet medical journal. Yet, some large centres in South Africa appear to have been relatively unaffected. Kathryn Cleary reports.
Some foreign nationals in South Africa, their community leaders, human rights lawyers and activists are concerned that their health needs are falling through the cracks. This was compounded during lockdown with some foreign nationals claiming they were refused healthcare and others now concerned they will be excluded from the vaccine rollout. Luvuyo Mehlwana reports.
On 17 February Sr Milanie Bennett administered the Johnson & Johnson vaccine to President Cyril Ramaphosa. Bienne Huisman tracked her down to learn more about her long journey to this historical moment.
Reproductive health experts say South Africa recorded a 30% increase in maternal deaths during lockdown compared to the same period in 2019. Suicide, a previously unrecognised cause of maternal mortality in the country, also increased and some experts believe the stressors of the COVID-19 pandemic played a role. Tiyese Jeranji reports.
After the 2019 elections, new MECs for Health (provincial ministers) were appointed in four of South Africa’s nine provinces. Less than two years later, three of the four are no longer in their jobs, writes Marcus Low.
For all the suffering and death the COVID-19 pandemic has caused over the last 12 months, it has arguably also provided a unique opportunity to test some of the mechanisms behind South Africa’s proposed National Health Insurance (NHI) system. The centralised procurement of vaccines and the contracting of doctors, for example, are probably not dissimilar from the arrangements we might see under NHI. Kathryn Cleary asks three leading health experts what lessons, for NHI, we should learn from the COVID-19 response.
In late January, Dr Anban Pillay, Deputy Director-General in South Africa’s National Department of Health, revealed that South Africa would pay more than double the price paid by the European Union (EU) for AstraZeneca’s COVID-19 vaccine. This set off a flurry of questions on how vaccine prices are set and why, in many cases, the prices themselves are not known to the public. Catherine Tomlinson takes a closer look at the issues involved.
The National Council of Provinces convened on Thursday to receive an update on the country’s vaccine acquisition and rollout plan. Elri Voigt has the details of what provinces reported.
The national budget tabled this week shows that planned spending on public health is reduced by a massive R50.3 billion over the next three years. We cannot accept a vaccine versus health system trade-off. Government must both expedite the procurement of vaccines and ensure that provinces have the staff and other capabilities to rapidly roll them out and to maintain and improve the quality of healthcare services, argue writers from SECTION27.
Government deserves criticism for various aspects of its COVID-19 response, but some social media criticism following Sunday’s announcement that the Oxford University/AstraZeneca vaccine has little or no efficacy in preventing mild-to-moderate disease caused by the 501Y.V2 variant has been unfair, writes Marcus Low.
While local experts generally welcome the order in which vaccines will be provided to different categories of people in South Africa, they are concerned that some practical nuances are unclear. Elna Schütz reports.
Over 150 000 people who had TB in South Africa in 2018 were not diagnosed, according to findings from South Africa’s long-awaited National Tuberculosis Prevalence Survey. One reason for this is that an unexpectedly high number of people do not show the typical TB symptoms and are never x-rayed. Amy Green reports.
